Link to this article by the psychiatrist Joanna Moncrieff:
"Royal College of Psychiatrists rejects discussion of crucial research on antipsychotics"
Some leading psychiatrists have been publicly critical of the overhyping of antipsychotics (7) and there are undoubtedly many others who are concerned about these research findings and trying to avoid antipsychotic drug treatment if possible, and use low doses for short periods where not. I have expressed the hope that as this research becomes more widely known, others will follow suit.
My illusions were recently shattered, however, by the Royal College of Psychiatrists’ conference planning committee. Recently I proposed a symposium for the 2014 annual conference entitled ‘Re-evaluating antipsychotics- time to change practice?’ I invited Lex Wunderink, the first author of the Dutch study, to discuss his study, along with a leading British psychiatrist involved in brain scanning studies of people with schizophrenia. I was confident the symposium would be accepted, because obviously, I thought, the conference committee would recognise the importance of this research, and want to ensure it was widely publicised to, and debated by, members of the profession.
To my astonishment it was rejected. I wrote to the conference organiser to ask why, pointing out that patients, carers and the general public are wondering what the profession is doing about these research findings. They would be most surprised to know that the profession did not consider the results sufficiently interesting to merit discussion at the principal meeting of UK psychiatrists. She replied that there were too many competing suggestions. So I asked if any of the symposia selected covered these same areas of research. I did not get a reply.